DCVA and RegMed XB: Two initiatives, One philosophy.
We are delighted to invite you to a special edition of the DCVA & RegMed XB Valorization Community event: “Venturing into New Waters – The
📅 May 21st, 2024, from 3:00 PM to 6:00 PM (incl. drinks) 📍 Loyens & Loeff in Amsterdam This event is for: 🔬 Academic researchers in life sciences and
July 5, 2023 in F1RST Portfolio News • New Investor Libertatis Ergo Holding joins the financing round alongside existing investors FIRST Fund, KIKK Capital and Oost NL•
May 9, 2023 in F1RST Portfolio News 08 May 2023, Naarden, The Netherlands – Phlox Therapeutics (“Phlox”), a private biotechnology company specializing in developing innovative RNA-therapeutics for rare
In 2022, Dr. Bart Spee and Dr. Kerstin Schneeberger were awarded a RegMed XB Thematic Transfer Voucher, facilitating market analysis for their innovative bioreactor technology, the RPMotion.
Copyright © 2023 · TTTransfer · Design by Siracle Creatives
